Search Within

Paul Marks

Formats
  1. Journal Article (121)
  2. Meeting Abstract (47)
  3. Book Section (10)
  4. Book Whole (4)
  5. Conference Paper (4)
Groups
  1. Department of Medicine (18)
  2. Center for Hematologic Malignancies (15)
  3. Solid Tumor Oncology Division (14)
  4. Surgery (13)
  5. GSK Faculty (12)
  6. Genitourinary Oncology Service (12)

More Groups

People
  1. Richard Rifkind (113)
  2. Victoria Richon (77)
  3. Lang Ngo (27)
  4. Gisela Venta-Perez (20)
  5. William Kelly (16)
  6. Weisheng Xu (13)

More People

Years
  1. 2015 (2)
  2. 2014 (2)
  3. 2013 (3)
  4. 2012 (4)
  5. 2011 (3)
  6. 2010 (6)

More Years

Publications
  1. Proceedings of the National Academy of Sciences of the United States of America (35)
  2. Proceedings of the American Association for Cancer Research Annual Meeting (19)
  3. Cancer Research (15)
  4. Blood (9)
  5. Clinical Cancer Research (9)
  6. Anticancer Research (5)

More Publications

Publishers
  1. American Association for Cancer Research (48)
  2. National Academy of Sciences (35)
  3. American Society of Hematology (9)
  4. Nature Publishing Group (8)
  5. Elsevier Inc. (7)
  6. John Wiley & Sons (6)

More Publishers

Results (186)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cloning of the cDNA encoding phenylalanyl tRNA synthetase α-subunit-like protein whose expression is down regulated during differentiation
    Meeting Abstract

    Zhou, X.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (1999)

    Fulltext@MSK | Save
  • The hydroxamic acid class of hybrid polar cytodifferentiation agents are potent inhibitors of histone deacetylase activity
    Meeting Abstract

    Richon, V. M.; Tolentino, T.; Breslow, R.; Rifkind, R. A.; Marks, P. A.
    Proceedings of the American Association for Cancer Research Annual Meeting (1999)

    Fulltext@MSK | Save
  • The conquest of cancer
    Journal Article

    Marks, P. A.
    Scientist (1999)

    Fulltext@MSK | Save
  • Health care reform: Has it really begun?
    Journal Article

    Marks, P. A.
    Academic Medicine (1999)

    Fulltext@MSK | Save
  • Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
    Journal Article

    Finnin, M. S.; Donigian, J. R.; Cohen, A.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.; Breslow, R.; Pavletich, N. P.
    Nature (1999)

    Fulltext@MSK | Save
  • Photoaffinity labeling and mass spectrometry identify ribosomal protein S3 as a potential target for hybrid polar cytodifferentiation agents
    Journal Article

    Webb, Y.; Zhou, X.; Ngo, L.; Cornish, V.; Stahl, J.; Erdjument-Bromage, H.; Tempst, P.; Rifkind, R. A.; Marks, P. A.; Breslow, R.; more...
    Journal of Biological Chemistry (1999)

    Fulltext@MSK | Save
  • Cloning of the cDNA encoding phenylalanyl tRNA synthetase regulatory α-subunit-like protein whose expression is down-regulated during differentiation
    Journal Article

    Zhou, X.; Richon, V. M.; Ngo, L.; Rifkind, R. A.; Marks, P. A.
    Gene (1999)

    Fulltext@MSK | Save
  • Hybrid polar inducers of transformed cell differentiation/apoptosis. From the cell to the clinic
    Journal Article

    Marks, P. A.; Richon, V. M.; Breslow, R.; Rifkind, R. A.
    Comptes Rendus de l'Academie des Sciences - Serie 3 (1999)

    Fulltext@MSK | Save
  • Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma
    Journal Article

    Glick, R. D.; Swendeman, S. L.; Coffey, D. C.; Rifkind, R. A.; Marks, P. A.; Richon, V. M.; La Quaglia, M. P.
    Cancer Research (1999)

    Fulltext@MSK | Save
  • Chemoprevention of carcinogen-induced mammary tumorigenesis by the hybrid polar cytodifferentiation agent, suberanilohydroxamic acid (SAHA)
    Journal Article

    Cohen, L. A.; Amin, S.; Marks, P. A.; Rifkind, R. A.; Desai, D.; Richon, V. M.
    Anticancer Research (1999)

    Fulltext@MSK | Save